🔗 Permalink

Inventor profile of:

Heike Keilhack

City:

Belmont, Massachusetts

Country:

United States

Published Applications:

71

Last publication date:

2025-05-29

Top Assignees for applications by Heike Keilhack

The entities that hold a legal rights for patent applications filed by inventor Keilhack Heike:

EPIZYME, INC. 35 Cambridge, MA United States
EISAI R&D MANAGEMENT CO., LTD. 6 Tokyo, Japan
HEALTH RESEARCH, INC. 2 Buffalo, NY United States
The Regents of the University of Colorado, a body corporate 1 Denver, CO United States

Recent patent applications by Keilhack Heike

Heike Keilhack from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250170138A1

Human necessities

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

#2 | 2025-05-22

US20250163033A1

Chemistry; metallurgy

METHODS OF TREATING CANCER

#3 | 2025-05-15

US20250152598A1

Human necessities

METHOD FOR TREATING CANCER

#4 | 2025-04-03

US20250109123A1

Chemistry; metallurgy

COMBINATION THERAPY FOR TREATING CANCER

#5 | 2025-02-27

US20250064822A1

Human necessities

METHOD FOR TREATING CANCER

#6 | 2024-09-05

US20240293419A1

Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#7 | 2024-08-22

US20240277723A1

Human necessities

Aryl-or heteroaryl-substituted benzene compounds

#8 | 2024-07-25

US20240245698A1

Human necessities

Aryl-OR heteroaryl-substituted benzene compounds

#9 | 2024-07-25

US20240245697A1

Human necessities

Aryl-or heteroaryl-substituted benzene compounds

#10 | 2024-02-22

US20240058348A1

Human necessities

EZH2 INHIBITORS FOR TREATING LYMPHOMA

#11 | 2024-01-25

US20240024331A1

Human necessities

METHOD FOR TREATING CANCER

#12 | 2022-10-06

US20220315566A1

Chemistry; metallurgy

Methods of treating cancer

#13 | 2022-09-08

US20220281854A1

Chemistry; metallurgy

COMBINATION THERAPY FOR TREATING CANCER

#14 | 2022-07-21

US20220226336A1

Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#15 | 2022-07-14

US20220218714A1

Human necessities

METHOD OF TREATING CANCER

#16 | 2022-06-09

US20220175789A1

Human necessities

EZH2 inhibitors for treating lymphoma

#17 | 2022-05-26

US20220160721A1

Human necessities

METHODS OF TREATING CANCER

#18 | 2021-12-09

US20210379076A1

Human necessities

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

#19 | 2021-11-18

US20210353632A1

Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#20 | 2021-09-02

US20210267990A1

Human necessities

METHOD FOR TREATING CANCER

#21 | 2021-07-15

US20210213027A1

Human necessities

Method for treating cancer

#22 | 2021-04-29

US20210121470A1

Human necessities

METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR

#23 | 2021-03-04

US20210060030A1

Human necessities

Method for treating cancer

#24 | 2021-02-25

US20210053948A1

Chemistry; metallurgy

Combination therapy for treating cancer

#25 | 2021-01-14

US20210008075A1

Human necessities

PEDIATRIC DOSING FOR TREATMENT OF CANCER WITH AN EZH2 INHIBITOR

#26 | 2020-10-22

US20200330472A1

Human necessities

METHOD OF TREATING CANCER

#27 | 2020-10-15

US20200323866A1

Human necessities

EZH2 inhibitors for treating lymphoma

#28 | 2020-10-15

US20200323865A1

Human necessities

METHODS OF TREATING CANCER

#29 | 2020-08-27

US20200268765A1

Human necessities

METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR

#30 | 2020-08-20

US20200262823A1

Chemistry; metallurgy

METHODS OF TREATING CANCER

#31 | 2020-05-21

US20200155562A1

Human necessities

Aryl-or heteroaryl-substituted benzene compounds

#32 | 2020-05-21

US20200155561A1

Human necessities

Method for treating cancer

#33 | 2020-05-07

US20200138825A1

Human necessities

METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR

#34 | 2020-04-16

US20200113911A1

Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#35 | 2020-04-02

US20200101081A1

Human necessities

Combination therapy for treating cancer

#36 | 2020-01-23

US20200022987A1

Human necessities

EZH2 INHIBITORS FOR TREATING LYMPHOMA

#37 | 2020-01-09

US20200009152A1

Human necessities

Method for treating cancer

#38 | 2019-10-17

US20190315725A1

Chemistry; metallurgy

Combination therapy for treating cancer

#39 | 2019-08-22

US20190255060A1

Human necessities

EZH2 inhibitors for treating lymphoma

#40 | 2019-08-08

US20190240230A1

Human necessities

METHOD OF TREATING CANCER

#41 | 2019-06-13

US20190175604A1

Human necessities

EZH2 INHIBITORS FOR TREATING LYMPHOMA

#42 | 2019-04-04

US20190100514A1

Chemistry; metallurgy

METHODS OF TREATING CANCER

#43 | 2019-03-21

US20190083504A1

Human necessities

METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR

#44 | 2019-03-07

US20190070188A1

Human necessities

PEDIATRIC DOSING FOR TREATMENT OF CANCER WITH AN EZH2 INHIBITOR

#45 | 2019-02-07

US20190038633A1

Human necessities

METHODS OF TREATING CANCER

#46 | 2018-11-08

US20180318309A1

Human necessities

Aryl-or heteroaryl-substituted benzene compounds

#47 | 2018-11-01

US20180311251A1

Human necessities

EZH2 INHIBITORS FOR TREATING LYMPHOMA

#48 | 2018-10-18

US20180296563A1

Human necessities

METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR

#49 | 2018-10-11

US20180289717A1

Human necessities

Combination therapy for treating cancer

#50 | 2018-10-04

US20180280402A1

Human necessities

Combination therapy for treating cancer

#51 | 2018-08-23

US20180235975A1

Human necessities

Method for treating cancer

#52 | 2018-05-17

US20180133224A1

Human necessities

Method for treating cancer

#53 | 2018-03-15

US20180071300A1

Human necessities

METHOD OF TREATING CANCER

#54 | 2017-12-21

US20170360797A1

Human necessities

Method for treating cancer

#55 | 2017-10-26

US20170305890A1

Chemistry; metallurgy

METHODS OF TREATING CANCER

#56 | 2017-10-26

US20170305889A1

Chemistry; metallurgy

METHODS OF TREATING CANCER

#57 | 2017-09-07

US20170252349A1

Human necessities

Aryl-or heteroaryl-substituted benzene compounds

#58 | 2017-08-03

US20170216300A1

Human necessities

EZH2 inhibitors for treating lymphoma

#59 | 2017-05-04

US20170119780A1

Human necessities

Aryl- or heteroaryl-substituted benzene compounds

#60 | 2016-12-01

US20160346293A1

Human necessities

Method for treating cancer

#61 | 2016-11-17

US20160332969A1

Chemistry; metallurgy

SUBSTITUTED BENZENE COMPOUNDS

#62 | 2016-10-20

US20160303135A1

Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#63 | 2016-08-11

US20160228447A1

Human necessities

METHOD OF TREATING CANCER

#64 | 2016-01-28

US20160022693A1

Human necessities

Aryl- or heteroaryl-substituted benzene compounds

#65 | 2015-12-10

US20150353494A1

Chemistry; metallurgy

Aryl- or heteroaryl-substituted benzene compounds

#66 | 2015-02-19

US20150051163A1

Chemistry; metallurgy

Combination therapy for treating cancer

#67 | 2014-09-25

US20140288041A1

Chemistry; metallurgy

Aryl- or heteroaryl-substituted benzene compounds

#68 | 2014-05-22

US20140142083A1

Chemistry; metallurgy

Dihidropyridin-2-one benzamine compounds

#69 | 2014-05-08

US20140128393A1

Chemistry; metallurgy

Methods of treating cancer

#70 | 2013-05-16

US20130123234A1

Chemistry; metallurgy

Aryl- or heteroaryl-substituted benzene compounds

#71 | 2012-10-18

US20120264734A1

Human necessities

Aryl- or heteroaryl-substituted benzene compounds

InventorID:

249128 ⎘